Parameter | Breakdown | n | % |
---|---|---|---|
Sex | Male | 129 | 39.4 |
Female | 198 | 60.6 | |
Age | ≦60 | 141 | 43.1 |
61≦ | 186 | 56.9 | |
Employment status | Unemployed | 87 | 26.6 |
Full time employee | 84 | 25.7 | |
Homemaker | 76 | 23.2 | |
Part time employee | 40 | 12.2 | |
Retired | 40 | 12.2 | |
Performance status | 0 | 78 | 23.9 |
1 | 218 | 66.7 | |
2 | 31 | 9.5 | |
Tumor location | Gastrointestinal organs | 121 | 37.0 |
Breast | 79 | 24.2 | |
Female reproductive organs | 47 | 14.4 | |
Blood/hematopoietic system | 40 | 12.2 | |
Respiratory organs | 15 | 4.6 | |
Other/unknown | 25 | 7.6 | |
Stage | I | 25 | 7.6 |
II | 54 | 16.5 | |
III | 86 | 26.3 | |
IV | 160 | 48.9 | |
Unknown | 2 | 0.6 | |
CTCAE Peripheral sensory neuropathy | Grade 1 | 120 | 36.7 |
Grade 2 | 189 | 57.8 | |
Grade 3 | 18 | 5.5 | |
Paresthesia of the hands and feet | hands | 45 | 13.8 |
feet | 33 | 10.1 | |
Both hands and feet | 249 | 76.1 | |
Drug used | Paclitaxel | 146 | 44.6 |
Oxaliplatin | 85 | 26.0 | |
Vincristine | 33 | 10.1 | |
Docetaxel | 29 | 8.9 | |
Cisplatin | 11 | 3.4 | |
Carboplatin | 2 | 0.6 | |
Vinblastine | 2 | 0.6 | |
Other | 19 | 5.8 |